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Abstract
Development of new classifications of inhibitors are essential in order
to control infectious diseases. Currently the only antibiotics available
follow two approaches: inhibition of cell wall remodeling and protein
synthesis. DapE is part of the succinylase biosynthetic pathway and is
important to the production of lysine and mDap (mesodiaminopimelate) both of which synthesize protein and bacterial
peptidoglycan cell wall remodeling. Due to increasing bacterial
resistance, a new method of treatment is critical through inhibition of
the enzymatic activity of DapE. There is no evidence of DapE in
mammals, therefore, inhibition should be selective in thwarting
bacterial growth. High-Throughput Screening (HiTS) was utilized to
screen over 33,000 different compounds which identified several
inhibitors of DapE. Computational chemistry uses the x-ray determined
structure of DapE to perform molecular docking. The application of
this process could lead to the discovery of other possible inhibitors as
new antibiotics.

Molecular Dynamics (MD)
The focus of this project is to analyze and design particular
molecules that could bind to DapE using molecular dynamic (MD)
simulations. These simulations help us visualize the different sites
of the DapE molecule and also helps us choose potential inhibitors
that could bind to the binding sites. Molecular Dynamics (MD) can
be a very useful tool in understanding interactions and calculating
the energies of interactions. It is also useful because it calculates
the electrostatic, Van der Waals and total forces of these
interactions. These processes are run on mini-supercomputers in
the computational lab and simulates how the ligand interacts with
the binding site of DapE to minimize the binding energy.

Background
A plausible bacterial target that is both present in Gram-negative and
some Gram-positive bacteria is the DapE-encoded N-succinyl-L, Ldiaminopimelic acid desuccinylase which is apart of the lysine
biosynthetic pathway. This pathway contains several different enzymes
that could provide probable drug targets. Lysine and mesodiaminopimelate (mDAP) are products from this pathway that are
needed to produce protein and peptidoglycan cell wall synthesis.
Lysine cannot be synthesized in humans, so it is an essential amino
acid meaning that it must be consumed. The deletion of the DapE gene
in mDAP/lysine biosynthetic pathway is lethal because it is crucial for
cell growth and proliferation. There are no biosynthetic pathways
involving DapE in mammals, so inhibitors that target DapE exhibit
selective toxicity against bacteria and have little effect on humans. This
makes DapE a promising target of antibiotics and effective method in
treating bacterial infections.

PDB ID

Bacterial Species

1VGY

Neisseria
Meningitidis
Haemophilus
Influenzae

3IC1

A

(a)

B

Figure 3 – A. Products of DapE interacting with 2
Arg residues in structure 5VO3. B. Sulfate ions
bound to the same Arg residues in structure 5UEJ.

Crystallization Conditions

Number of Zinc’s in active
sites
Not listed in the article or the PDB file. Zero

Number of Sulfates in
Active Site
Zero

Distance from Sulfates to Closest Zinc/
Relevant Residues (Å)
N/A

1 M ammonium sulfate, 0.2 M NaCl,
and 0.1 M sodium acetate, pH 4.4

One in Chain A,
Three in Chain B

Chain A: 3.1 to Arg179, about 3 to Arg258,
about 5.2 to Arg178. 14 to Zn
Chain B: Sulfate 1 is 3 to Zn, but no other
residues within 7
Sulfate 2 is 13 to Zn, 2.5 to Arg178 and 4.5 to
Arg179
Sulfate 3: 9.2 to Zn and 3 to both Arg329 and
Arg258
Chain A: 2.7 to Arg178, 2.9 to Arg179, 6.5 to
both Arg258 and Arg329. 13 to Zn
Chain B: 2.9 to Arg178, 4.5 to Arg329, 3.7 to
Arg258 and 2.8 to Arg179. 13.5 to Zn
Chain A: 3.25 to Arg259, 3.8 to His195, 11.5 to
Zn
Chain B: 2.9 to Arg259, 2.6 to His195, 7.8 to
Zn
Chain A: 2.8 to Arg259,
8.8 to Zn

Two

3ISZ

Haemophilus
Influenzae

Same as 3IC1

One

One in Chain A,
One in Chain B

4O23

Neisseria
Meningitidis

One in Chain A,
Two in Chain B

One in Chain A,
One in Chain B

4PPZ

Neisseria
Meningitidis

Two in Chain A

One in Chain A

4PQA

Neisseria
Meningitidis

[20% (w/v) PEG 3350 and 100 mM
HEPES (pH 7.5)]
The PDB file also lists
0.1 M succinic acid
[15% (w/v) PEG 3350 and 100 mM
succinic acid (pH 7.0)]
The PDB file also lists 0.2M Li2SO4 and
0.1M HEPES
0.2 M ammonium acetate, 0.1 M TRIS
(pH 8.5), and 25% (w/v) polyethylene
glycol 3350]

Two in Chain A

One in Chain A,
Also Captopril
Is bound

Chain A: 2.9 to Arg259, 8.65 to Zn

4ONW

Vibrio Cholerea

(20% (v/v) 1,4-butanediol, 0.1 M
sodium acetate pH 4.5)

Zero

Zero

Only the Catalytic Domain is crystallized in this
structure

4OP4

Vibrio Cholerea
Haemophilus
Influenzae

Two in Chain A,
Two in Chain B
Two in Chain A,
Two in Chain B

Zero

4H2K

(20% (v/v) 1,4-butanediol, 0.1 M
sodium acetate pH 4.5)
(0.2 M ammonium acetate, 0.1 M BISTRIS pH 5.5, 25% (w/v) polyethylene
glycol 3350)

Only the Catalytic Domain is crystallized in this
structure
Only the Catalytic Domain is crystallized in this
structure

5UEJ

Neisseria
Meningitidis

From PDB File:
0.2M Li2SO4, 0.1M Tris:HCl, 1.26M
(NH4)2SO4, 0.05M DMSO, PH 8.5

Two in Chain A,
Two in Chain B

Two in Chain A,
Two in Chain B

5VO3

Haemophilus
Influenzae

0.05 M HEPES (pH 7.3), 10.7% (w/v)
Two in Chain A,
PEG MME 2000, and 8.6% (w/v) PEG Two in Chain B
2000
PDB File Lists 0.15M HEPES and 0.06M
Sodium Potassium Tartrate

Zero

None

Chain A: Sulfate 1 is 3.5 to Arg179, 8.4 to Zn
Sulfate 2 is 4 to Arg259, 12.65 to Zn
Chain B: Sulfate 1 is 3 to Arg179, 9 to Zn
Sulfate 2 is 3.
This was a products-bound closed structure

Results
The initial inhibitor is a bis-sulfonate with eight methylene groups
separating the sulfonates (Figure 4), which were placed in the
positions of the sulfate groups in Figure 3B. An adjustment of the
number of methylene groups can increase the binding affinity,
however eight methylene groups was chosen as the baseline. A
replacement of the sulfonates with neutral hydrogen-bonding
groups will take place to allow it to pass the membrane. Also a
replacement of some of the methylene groups with hydrogen
bonding groups will increase the affinity for the substrate binding
site. Using the sulfate binding sites seen in the X-ray structure of
DapE as guides to where the sulfonates would bind, we have
completed our initial simulation. The results show that the
compound with 8 methylene groups is not long enough for the most
effective binding.
Figure 2 – Lysine Biosynthesis Pathways: Bacteria use the pathway on the left but mammals do not.

Figure 4. Shown above is initial inhibitor tested on the enzyme DapE called
octane-1,8-disulfonate.

Sulfate Ions Bound to DapE
A survey of DapE X-ray
structures displayed in the
table below shows that DapE
often binds sulfate ions.
These ions are bound in
positions that correspond to
the binding sites for the
products of the reaction as
seen in Figure 3.

Figure 1. DapE is in red and blue; Zn ions in silver.

Results

(b)

(c)

Figure 5. (a) Dimer of DapE binding initial inhibitor to both chains. (b) Closeup
of subunit A binding site with inhibitor bound. (c) Closeup of subunit B binding
site with inhibitor bound.
*DapE is in red and blue; Zn ions in silver; inhibitor in green or silver; amino acid
residues interacting with the inhibitor in atomic colors*

Interactions Energies
The interaction energies shown in the
table indicate that the best binding of
a bis-sulfonate would occur when the
chain had 16 methylene groups. This
somewhat surprising result indicates
that it needs flexibility to link the two
sulfate binding sites and that the
methylene chain also contributes to
the binding.

# of CH2
4
6
10
12
14
16
18

Elec
-288
-207
-195
-209
-254
-315
-230

VDW Total
-16 -294
-12 -219
-35 -230
-36 -245
-35 -289
-42 -357
-33 -263

*Energies are in kcal/mpe.
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